Wird geladen...
Hepatitis E virus infections in patients with MS on oral disease-modifying treatment
OBJECTIVE: To test whether patients with MS on disease-modifying treatments (DMTs) are at a higher risk of acute or chronic hepatitis E virus (HEV) infections or extrahepatic manifestations, we monitored approximately 1,100 persons with MS (pwMS) during 3 years for HEV infection. METHODS: This is an...
Gespeichert in:
| Veröffentlicht in: | Neurol Neuroimmunol Neuroinflamm |
|---|---|
| Hauptverfasser: | , , , , , , |
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
Lippincott Williams & Wilkins
2019
|
| Schlagworte: | |
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6705628/ https://ncbi.nlm.nih.gov/pubmed/31454772 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1212/NXI.0000000000000594 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|